Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type of Delivery”

693 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 693 results

Not applicableStudy completedNCT03838900
What this trial is testing

The Loop Observational Study

Who this might be right for
Diabetes Mellitus, Type 1
Jaeb Center for Health Research 1,212
Not applicableLooking for participantsNCT06876207
What this trial is testing

Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity

Who this might be right for
Type 1 Diabetes Mellitus
Bruno Bombaci 50
Not applicableActive Not RecruitingNCT07039617
What this trial is testing

Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)

Who this might be right for
Type 1 Diabetes
Sue Brown 40
Not applicableWithdrawnNCT06692153
What this trial is testing

Embecta AID System in Adults With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DM+4 more
Embecta Corp.
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Not applicableStudy completedNCT00899821
What this trial is testing

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Not applicableLooking for participantsNCT05849753
What this trial is testing

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1ChildDelivery of Health Care+1 more
Nemours Children's Clinic 50
Not applicableStudy completedNCT03315728
What this trial is testing

Pathways for Health Equity Quality Improvement Strategy

Who this might be right for
Diabetes Mellitus Type 2 With Hyperglycemia
Western University, Canada 4
Not applicableStudy completedNCT02366767
What this trial is testing

Assessment of an Automatic Closed-loop Insulin Delivery System

Who this might be right for
Diabetes Mellitus, Type 1
Stanford University 21
Not applicableEnded earlyNCT05299177
What this trial is testing

Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump

Who this might be right for
Type 1 Diabetes
Imperial College London 1
Testing effectiveness (Phase 2)Study completedNCT01319565
What this trial is testing

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 102
Post-approval studies (Phase 4)Study completedNCT00572052
What this trial is testing

Comparison of Glycemic Control Achieved With 2 Different Needles

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 62
Post-approval studies (Phase 4)Study completedNCT00569426
What this trial is testing

Evaluating the Use of Two Different Needles in Subjects With Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 119
Not applicableUnknownNCT04835350
What this trial is testing

Feasibility and Safety Study of the Automated Insulin Delivery Closed Loop System Pancreas4ALL

Who this might be right for
Type 1 Diabetes
Lenka Petruzelkova 16
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Not applicableStudy completedNCT05280925
What this trial is testing

Episodic Future Thinking to Improve Management of Type 2 Diabetes: Remote Delivery and Outcomes Assessment

Who this might be right for
Type 2 DiabetesOverweight and Obesity
Virginia Polytechnic Institute and State University 137
Not applicableLooking for participantsNCT07287943
What this trial is testing

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Who this might be right for
Type 1 DiabetesGastroparesis Due to Diabetes Mellitus Type I
Viral N. Shah 34
Testing effectiveness (Phase 2)Study completedNCT00443482
What this trial is testing

Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)

Who this might be right for
Asthma
Novartis 50
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Next Page